Search

everythinglearnresearchcommunity

for

Search:↓

Mice with LSS deficiency showed hair loss and cataracts, similar to humans, and can help in understanding and treating this condition.

Consider benefits and risks of new alopecia treatments for safety.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Delayed ejaculation is a complex issue caused by psychological, biological, and lifestyle factors, requiring a holistic treatment approach.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

Finasteride may increase erectile dysfunction risk in patients with benign prostatic hyperplasia.

Dutasteride works better than finasteride for hair loss, with both being safe to use.

FGF-2&D/P nanoparticles can help treat hair loss.

Sargassum muticum extract and its component apo-9'-fucoxanthinone may help hair growth and treat hair loss.

Finasteride slows down motherly behavior in first-time pregnant rats.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.

Metformin helps regulate menstrual cycles, induce ovulation, and improve pregnancy outcomes in women with PCOS.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

Melatonin-loaded nanocarriers improve melatonin delivery and effectiveness for various medical treatments.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Effective treatments for spinal and bulbar muscular atrophy are not yet available; more research is needed.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

Finasteride may cause lasting sexual, mental, and physical symptoms; use with caution.

Researchers developed a new method to find substances in herbs that can block a specific enzyme linked to hair loss.